Stay updated on Simufilam 100 mg in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.

Latest updates to the Simufilam 100 mg in Alzheimer's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision label (v3.4.2) replacing the previous v3.4.1, which is a minor document version update without changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed, with no visible changes to study content or eligibility criteria; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedPublications section added to the Study Details page, including a PubMed-listed article and a note that publications are automatically filled from PubMed. Revision: v3.3.4 was applied.SummaryDifference0.2%

- Check62 days agoChange DetectedLocations section updated with many new sites across the US and internationally, and numerous existing locations were removed. The revision version updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedPremier Research was added as a collaborator and Premier Research Group plc was removed in the Collaborators section (Revision: v3.3.2).SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the banner notice about government funding and NIH operating status. The study details and page functionality remain unaffected.SummaryDifference0.2%

Stay in the know with updates to Simufilam 100 mg in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.